The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2025
Filed:
Jul. 29, 2020
Applicant:
Evonik Operations Gmbh, Essen, DE;
Inventors:
Mario Gomez, Darmstadt, DE;
Bodo Speckmann, Kahl, DE;
Michael Schwarm, Alzenau, DE;
Oliver Werz, Jena, DE;
Assignee:
Evonik Operations GmbH, Essen, DE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 36/324 (2005.12); A23K 10/30 (2015.12); A23K 20/105 (2015.12); A23K 20/142 (2015.12); A23K 20/158 (2015.12); A23K 20/163 (2015.12); A23L 33/00 (2015.12); A23L 33/105 (2015.12); A23L 33/12 (2015.12); A23L 33/175 (2015.12); A61K 31/202 (2005.12); A61K 47/12 (2005.12); A61K 47/14 (2016.12); A61K 47/36 (2005.12);
U.S. Cl.
CPC ...
A61K 36/324 (2012.12); A23K 10/30 (2016.04); A23K 20/105 (2016.04); A23K 20/142 (2016.04); A23K 20/158 (2016.04); A23K 20/163 (2016.04); A23L 33/105 (2016.07); A23L 33/12 (2016.07); A23L 33/175 (2016.07); A23L 33/40 (2016.07); A61K 31/202 (2012.12); A61K 47/12 (2012.12); A61K 47/14 (2012.12); A61K 47/36 (2012.12); A23V 2002/00 (2012.12); A61K 2236/331 (2012.12); A61K 2236/37 (2012.12); A61K 2236/53 (2012.12);
Abstract
Preparations may include at least one extract of gum resins fromspecies and at least one omega-3 fatty acid salt selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Surprisingly, such combinations of extracts of gum resins fromspecies and polyunsaturated fatty acid salt can cause a marked and unexpected increase in the biosynthesis of specialized pro-resolving mediators (SPM) in a synergistic manner, proposing benefit for resolution of inflammatory conditions.